Related Experiment Video
Updated: Apr 22, 2026
08:24
A Method to Study α-Synuclein Toxicity and Aggregation Using a Humanized Yeast Model
Published on: November 25, 2022
2.2K
Rab11 modulates α-synuclein-mediated defects in synaptic transmission and behaviour.
Carlo Breda1, Marie L Nugent2, Jasper G Estranero1
1Department of Genetics, University of Leicester, University Road, Leicester LE1 7RH, UK.
Human Molecular Genetics
|October 12, 2014
Summary
Parkinson's disease (PD) involves alpha-synuclein (aSyn) aggregation. Overexpressing Rab11 protein reduces aSyn clumps and improves motor function and lifespan in fruit fly models of PD.
Area of Science:
- Neuroscience
- Cell Biology
- Genetics
Background:
- Parkinson's disease (PD) is characterized by Lewy bodies, primarily composed of alpha-synuclein (aSyn).
- aSyn gene mutations are linked to familial PD, and aSyn dysfunction impairs neuronal vesicle transport, contributing to neurodegeneration.
- Rab GTPases are crucial for vesicle trafficking, and their role in PD pathogenesis is under investigation.
Purpose of the Study:
- To investigate the role of the endosomal recycling factor Rab11 in Parkinson's disease pathogenesis.
- To explore how Rab11 affects alpha-synuclein toxicity and related cellular and behavioral phenotypes.
Main Methods:
- Utilized Drosophila melanogaster models to study alpha-synuclein toxicity.
- Examined synaptic vesicle size and alpha-synuclein aggregation.
- Assessed locomotor activity, dopaminergic neuron degeneration, and lifespan in fruit fly models.
Main Results:
- Alpha-synuclein (aSyn) increased synaptic vesicle (SV) size at the larval neuromuscular junction, an effect reversed by Rab11 overexpression.
- Rab11 overexpression reduced aSyn aggregation.
- Rab11 ameliorated aSyn-induced deficits in locomotor activity, dopaminergic neuron survival, and lifespan in fruit flies.
Conclusions:
- Rab11 plays a significant role in modulating synaptic vesicle size and enhancing synaptic function.
- Targeting Rab11 activity presents a potential therapeutic strategy for Parkinson's disease.
Related Concept Videos
01:24Parkinson Disease ll: Pathophysiology
11
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
11
01:37Neural Regulation
34.5K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
34.5K